latest news releases from the newsroom
Bodisen Biotech Inc.
Bodisen Biotech Anticipates Notice of Delisting from the Amex, Announces That It Will Delay the Filing of its Annual Report on Form 10-K and Provides Updated Information Regarding Stock Ownership
SHAANXI, China, March 20, 2007 (PRIME NEWSWIRE) -- Bodisen Biotech, Inc. (the "Company") (AMEX:BBC), (London:BODI), (website: www.bodisen.com) today is providing information regarding the Company's anticipated delisting from the American Stock Exchange (the "Amex"), the Company's delayed filing of its Annual Report on Form 10-K for the fiscal year ended December 21, 2006, information regarding a potential Company liability and updated information regarding the share ownership of Qiong Wang and Bo Chen, the company's prior and current chief executive officers.
Lundin Petroleum AB
ETAP TO EXERCISE ITS 20 PERCENT PARTICIPATION OPTION IN THE OUDNA FIELD, OFFSHORE TUNISIA
Lundin Petroleum AB (Lundin Petroleum) announces that ETAP, the Tunisian state
oil company, has decided to exercise its participation option to acquire a 20
percent interest in the Oudna field, offshore Tunisia. Following ETAP’s
participation, Lundin Petroleum and Atlantis Holding Norway AS will each hold
40 percent. Lundin Petroleum’s 2007 production forecast will not be impacted by
the exercise of the option which was assumed in the forecast.
The Oudna field development was successfully com